CVS Health has a new captain at the helm. David Joyner steps up to replace Karen Lynch as CEO, hoping to navigate the company through rough waters. The health care giant has been struggling a lot this year, with its stock dropping by about 19%. It's been a tough time for major pharmacy chains, competing with online rivals while dealing with slumping sales and rising costs.
Just this week, CVS had some bad news. They said their earnings for the third quarter will be way lower than Wall Street hoped. This isn't the first time they've had to lower their expectations this year. They're seeing more claims from their Medicare Advantage coverage, which is hurting them financially. Plus, their drugstore sales are down.
 Analysts were surprised by the leadership change. But it makes sense, given that CVS hasn't been performing well lately. Lynch had just taken over the insurance segment, but the company’s still not hitting its marks. Glenview Capital Management, a hedge fund that owns shares in CVS, recently criticized the company for not living up to its potential.
Joyner is no rookie in the health care world. He's got 37 years of experience and has been with CVS for a while. He'll also join the board. Chairman Roger Farah will now have an executive role, too. They hope Joyner can help CVS face its challenges and make the best of its unique position in the market.

CVS Health Chooses a New Captain Amidst Sinking Stock and health Challenges

Actions